Comprehensive analysis of the efficacy and safety of CAR T-cell therapy in patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: a systematic review and meta-analysis

AbstractBackground Relapse/refractory B-cell acute lymphoblastic leukaemia (r/r B-ALL) represents paediatric cancer with a challenging prognosis. CAR T-cell treatment, considered an advanced treatment, remains controversial due to high relapse rates and adverse events. This study assessed the effica...

Повний опис

Бібліографічні деталі

Автори:	Sebastian Emmanuel Willyanto, Yohanes Audric Alimsjah, Krisanto Tanjaya, Aekkachai Tuekprakhon, Aulia Rahmi Pawestri
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Taylor & Francis Group 2024-12-01
Серія:	Annals of Medicine
Предмети:	CAR T-cell therapy immunotherapy acute lymphoblastic leukaemia targeted therapy oncoimmunology
Онлайн доступ:	https://www.tandfonline.com/doi/10.1080/07853890.2024.2349796
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!